Vasomotor symptoms linked to increased risk for Alzheimer’s disease
Sep 27, 2023
Objectively assessed VMS (so-called hot flashes), including sleep VMS, are associated with significantly lower amyloid-β42/40.
Operational design for a dementia-focused future
By
Mimi DeVinney
Aug 28, 2023
An increasing number of providers of services for seniors will be required to serve people with dementia and their caregivers across all levels of care. Aligning all facets of operations to serve this...
Helping residents stay sharp and mentally healthy
By
Lois A. Bowers
Jul 24, 2023
A study published online last week by the Journal of the American Geriatrics Society shared the frightening finding that “cognitive functioning may decline at an accelerated rate immediately post-retirement.”...
Memory care certification launches for assisted living communities
By
Lois A. Bowers
Jul 12, 2023
The Joint Commission, in collaboration with the Alzheimer’s Association, has launched a memory care certification program for assisted living communities.
New law implements training, exam requirements for assisted living employees
By
Lois A. Bowers
Jun 27, 2023
A new law in Texas requires managers and caregivers at assisted living communities serving people living with dementia to complete four hours of dementia-related training and pass an exam about dementia,...
Allopurinol may cut risk for neurodegenerative diseases
May 19, 2023
Allopurinol linked to 13 to 34 percent lower risk for Parkinson disease, Alzheimer disease, ALS
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Focus on briefs: Dementia
Feb 01, 2023
Alzheimer’s blood test, Aducanumab approval issues, Medicare coverage of brain scans that diagnose dementia, Some at higher risk for Alzheimer’s
A memorable tree
By
Lois A. Bowers
Jan 04, 2023
Photos of residents of Vista West adorned the Christmas tree in the drawing room in the Wisconsin governor’s residence this year. Find out more, and learn how to submit your photos!
Alzheimer’s experts throw support behind experimental drug despite adverse events, deaths
By
Kimberly Bonvissuto
Dec 01, 2022
Alzheimer’s disease experts are throwing their support behind the drug lecanemab, despite reports of two deaths tied to the experimental monoclonal antibody medication.